| Drug Name |
Spectinomycin hydrochloride |
| Drug ID |
BADD_D02064 |
| Description |
An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of gonorrhea. |
| Indications and Usage |
For use in the treatment of acute gonorrheal urethritis and proctitis in the male and acute gonorrheal cervicitis and proctitis in the female when due to susceptible strains of Neisseria gonorrhoeae. |
| Marketing Status |
approved; investigational; vet_approved |
| ATC Code |
J01XX04 |
| DrugBank ID |
DB00919
|
| KEGG ID |
D00869
|
| MeSH ID |
D000198
|
| PubChem ID |
64769
|
| TTD Drug ID |
D02PCR
|
| NDC Product Code |
66405-0003; 66603-818; 76321-0001; 55500-0006 |
| UNII |
HWT06H303Z
|
| Synonyms |
Spectinomycin | Actinospectacin | Prospec | Ferkel Spectam | Spectam, Ferkel | Kempi | Spectinomycin Dihydrochloride, Pentahydrate | Spectam | Spectinomycin Dihydrochloride, Anhydrous | Trobicin | Salmosan-T | Salmosan T | Stanilo | Spectinomycin Hydrochloride | Adspec |
